Washington, D.C. – In response to a joint release from the U.S. Food & Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) … Read More

The post ACLA Statement on LDT Proposed Rule Comments by FDA and CMS appeared first on American Clinical Laboratory Association.